Selective increases in regional brain glucocorticoid: A novel effect of chronic alcohol

Neuroscience

Volumn 156, Issue 4, 2008, Pages 1017-1027

  Little, H J ^a   Croft, A P ^b   O'Callaghan, M J ^c   Brooks, S P ^d   Wang, G ^a   Shaw, S G ^e  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^c UNIVERSITY OF ABERDEEN   (United Kingdom)

^d CARDIFF UNIVERSITY   (United Kingdom)

^e UNIVERSITY OF BERN   (Switzerland)

Author keywords

alcohol; corticosterone; glucocorticoid; withdrawal

Indexed keywords

ALCOHOL; CORTICOSTERONE; GLUCOCORTICOID;

ARTICLE; BRAIN REGION; CONTROLLED STUDY; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MALE; MASS SPECTROMETRY; MOUSE; NONHUMAN; PRIORITY JOURNAL; RADIOIMMUNOASSAY; RAT;

ANIMALS; BEHAVIOR, ANIMAL; BRAIN; BRAIN CHEMISTRY; CENTRAL NERVOUS SYSTEM DEPRESSANTS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CORTICOSTERONE; DRUG ADMINISTRATION SCHEDULE; ETHANOL; MICE; MICE, INBRED C57BL; PROTEIN BINDING; RADIOIMMUNOASSAY; RATS; RECEPTORS, GLUCOCORTICOID; TIME FACTORS;

EID: 54049114593     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2008.08.029     Document Type: Article

References (66)

1. Adinoff B., Martin P.R., Bone G.H., Eckhardt M.J., and Roerich L. Hypothalamic-pituitary adrenal axis functioning and cerebrospinal fluid corticotrophin releasing hormone and corticotropin levels in alcoholics after recent and long term abstinence. Arch Gen Psychiatry 47 (1990) 325-330
2. Ahmed A., Saksena S., Olliff S.P., Elias E., and Stewart P.M. Induction of hepatic 11β-hydroxysteroid dehydrogenase type 1 in patients with alcoholic liver disease. Clin Endocrinol 68 (2008) 898-903
3. Bailey C.P., O'Callaghan M.J., Croft, Manley S., and Little H.J. Alterations in mesolimbic dopamine function during the abstinence period following chronic ethanol consumption. Neuropharmacology 41 (2001) 989-999
4. Bailey C.P., Andrews N., McKnight A.T., Hughes J., and Little H.J. Prolonged changes in neurochemistry of dopamine neurons after chronic ethanol consumption. Pharmacol Biochem Behav 66 (2000) 153-161
5. Bates M.E., Bowdon S.C., and Barry D. Neurocognitive impairment associated with alcohol use disorders: implications for treatment. Exp Clin Psychopharmacol 10 (2002) 193-212
6. Bowdon S.C., Crews F.T., Bates M.E., Fals-Stewart W., and Ambrose M.L. Neurotoxicity and neurocognitive impairments with alcohol and drug-use disorders: potential roles in addiction and recovery. Alchohol Clin Exp Res 25 (2001) 317-321
7. Brooks S.P., Croft A.P., Norman G., Shaw S.G., and Little H.J. Nimodipine prior to alcohol withdrawal prevents memory loss during the abstinence phase; possible involvement of brain glucocorticoid. Neuroscience (2008) in press
8. Butte J.C., Kakihana R., and Noble E.P. Rat and mouse brain corticosterone. Endocrinology 90 (1972) 1091-1100
9. Cho K., and Little H.J. Corticosterone increases excitatory amino acid responses of ventral tegmental neurons. Neuroscience 88 (1999) 837-845
10. Croft A.P., O'Callaghan M.J., Shaw S.G., Connolly G., Jacquot C., and Little H.J. Effects of minor laboratory procedures, adrenalectomy, social defeat or acute alcohol on regional brain concentrations of corticosterone. Brain Res (2008) in press
11. Davies E., and MacKenzie S.M. Extra-adrenal production of corticosteroids. Clin Exp Pharmacol Physiol 30 (2003) 437-445
12. Dhabhar F.S., Miller A.H., McEwan B.S., and Spencer R.S. Differential activation of adrenal steroid receptors in neural and immune tissue of Sprague-Dawley, Fischer and Lewis rats. J Neuroimmunol 56 (1995) 77-90
13. Diez J.A., Sze P.Y., and Ginsburg B.E. Postnatal development of mouse plasma and brain corticosterone levels: new findings contingent upon the use of a competitive protein-binding assay. Endocrinology 98 (1975) 1434-1442
14. Durand D., and Carlen P.L. Decreased neuronal inhibition in vitro after long-term administration of ethanol. Science 224 (1984) 1359-1361
15. Erickson K., Drevets W., and Schulkin J. Glucocorticoid regulation of diverse cognitive function in normal and pathological emotional states. Neurosci Biobehav Rev 27 (2003) 233-246
16. Fadda F., and Rossetti Z.L. Chronic ethanol consumption: from neuroadaptation to neurodegeneration. Prog Neurobiol 55 (1998) 1-47
17. Fahlke C., Engel J.A., Eriksson C.P.J., Hard E., and Soderpalm B. Involvement of corticosterone in the modulation of ethanol consumption in the rat. Alcohol 3 (1994) 195-202
18. Fahlke C., and Erickson C.J. Effect of adrenalectomy and exposure to corticosterone on alcohol intake in alcohol preferring and alcohol avoiding rat lines. Alcohol Alcohol 35 (2000) 139-144
19. World Health Organization. Global status report on alcohol (2004), Department of Mental Health and Substance Abuse, Geneva
20. Haorah J., Knipe B., Gorantla S., Zheng J.L., and Persidsky Y. Alcohol-induced blood-brain barrier dysfunction is mediated via inositol 1,4,5-triphosphate receptor (IP3R)-gated intracellular calcium release. J Neurochem 100 (2007) 324-336
21. Harper C. The neuropathology of alcohol-specific brain damage, or does alcohol damage the brain?. J Neuropathol Exp Neurol 57 (1998) 101-110
22. Harper C., Dixon G., Sheedy D., and Garrick T. Neuropathological alterations in alcoholic brains. Studies arising from the New South Wales Tissue Resource Centre. Prog Neuropsychopharmacol Biol Psychiatry 27 (2003) 951-961
23. Ihara H., Berrios G.E., and London M. Group and case study of the dysexecutive syndrome in alcoholism without amnesia. J Neurosurg Neurol Psychiatry 68 (2000) 731-737
24. Irle E., and Markowitsch H.J. Widespread neuroanatomical damage and learning deficits following chronic alcohol consumption or vitamin B1 (thiamine) deficiency in rats. Behav Brain Res 9 (1983) 277-294
25. Jellinck P.H., Pavlides C., Sakai R.R., and McEwan B.S. 11-Beta-hydroxysteroid dehydrogenase functions reversibly as an oxoreductase in the rat hippocampus in vivo. J Steroid Biochem Mol Biol 71 (1999) 139-144
26. Kakihana R., Blum S., and Kessler S. Developmental study of pituitary-adrenal response in mice: plasma and brain corticosterone determination after histamine stress. J Endocrinol 60 (1974) 353-358
27. Karssen A.M., Meijer O.C., Van der Sandt I.C.J., Lucassen P.J., Lange E.C.M., De Boer A.G., and De Kloet E.R. Multidrug resistance P-glycoprotein hampers the access of cortisol, but not corticosterone to mouse and human brain. Endocrinology 142 (2001) 2686-2694
28. Khisti R.T., Boyd K.N., Kumar S., and Morrow A.L. Systemic ethanol administration elevates deoxycorticosterone levels and chronic ethanol exposure attenuates this response. Brain Res 1049 (2005) 104-111
29. Kril J.J., Halliday G.M., Svoboda M.D., and Cartright H. The cerebral cortex is damaged in chronic alcoholics. Neuroscience 79 (1997) 983-998
30. Leiber C.S., and DeCarli L.M. Liquid diet technique of ethanol administration: 1989 update. Alcohol Alcohol 24 (1989) 121-197
31. Lingvari I., and Liposits Z.S. Diurnal changes in endogenous corticosterone content of some brain regions of rats. Brain Res 124 (1977) 571-575
32. Linthorst A.C.E., Flachskamm C., Muller-Preuss P., Holsboer F., and Reul J.M.H.M. Effect of bacterial endotoxin and interleukin-1-beta on hippocampal serotonergic transmission, behavioural activity and free corticosterone levels: an in vivo microdialysis study. J Neurosci 15 (1995) 2920-2934
33. MacKenzie M., Clark C.J., Fraser R., Gomez-Sanchez C.E., Connell J.M., and Davies E. Expression of 11-beta-hydroxylase and aldosterone synthase genes in the rat brain. J Mol Endocrinol 24 (2000) 321-328
34. Magarinos A.M., Ferrini M., and De Nicola A. Corticosteroid receptors and glucocorticoid content in microdissected brain regions: correlative aspects. Neuroendocrinology 50 (1989) 673-678
35. Manley S., and Little H.J. Enhancement of amphetamine- and cocaine-induced locomotor activity after chronic ethanol administration. J Pharmacol Exp Ther 281 (1997) 1330-1339
36. Meaney M.J., Aitkin D.H., Sharma S., and Viau V. Basal ACTH, corticosterone and corticosterone-binding globulin levels over the diurnal cycle and age-related changes in hippocampal type I and type II corticosteroid receptor binding capacity in young and aged handled and non-handled rats. Neuroendocrinology 55 (1992) 204-213
37. Meijer O.C., Lange E.C.M., Briemer D.D., De Boer A.G., Workel J.O., and De Kloet E.R. Penetration of dexamethasone into brain glucocorticoid targets is enhanced in mdr1A P-glycoprotein knockout mice. Endocrinology 139 (1998) 1789-1998
38. Moisan M.P., Seckl J.R., and Edwards R.W. 11β-Hydroxysteroid dehydrogenase bioactivity and messenger RNA expression in rat forebrain: localization in hypothalamus, hippocampus and cortex. Endocrinology 127 (1990) 1450-1455
39. Morrow A.L., VanDoren M.J., Penland S.N., and Matthews D.B. The role of GABAergic neuroactive steroids in ethanol action, tolerance and dependence. Brain Res Rev 37 (2001) 98-109
40. Morton B., Ripley T., Whittington A., Butterworth A.R., and Little H.J. Evidence that changes in hippocampal excitability in vitro are caused by withdrawal from chronic in vivo ethanol administration. Alcohol Alcohol 27 (1992) 71-79
41. Mulholland P.J., Self R.L., Harris B.R., Little H.J., Littleton J.M., and Prendergast M.A. Corticosterone increases damage and cytosolic calcium accumulation associated with ethanol withdrawal in rat hippocampal slice cultures. Alcohol Clin Exp Res 29 (2005) 453-464
42. Nammi S., Dembele K., and Nyomba G. Increased 11-beta-hydroxysterid dehydrogenase type-1 and hexose-6-phosphate dehydrogenase in liver and adipose tissue of rat offspring exposed to alcohol in utero. Am J Physiol Regul Integr Comp Physiol 292 (2007) R1101-R1109
43. Noel X., Van der Linden M., Schmidt N., Sferrazza R., Hanak C., Le Bon O., De Mol J., Kornreich C., Pelc I., and Verbanck P. Supervisory attentional system in nonamnesic alcoholic men. Arch Gen Psychiatry 58 (2001) 1152-1158
44. O'Brien T.G. Human corticosteroid binding globulin. Clin Endocrinol 14 (1981) 192-212
45. O'Donnell D., Francis D., Weaver S., and Meaney M.M. Effects of adrenalectomy and corticosterone replacement on glucocorticoid receptor levels in rat-brain tissue: a comparison between Western blotting and receptor-binding assays. Brain Res 687 (1995) 133-142
46. Packan D.R., and Salplsky R.M. Glucocorticoid endangerment of the hippocampus: tissue, steroid and receptor specificity. Neuroendocrinology 51 (1990) 613-618
47. Pardridge W.M., Sakiyama R., and Judd H.L. Protein-bound corticosteroid in human serum is selectively transported into rat brain and liver in vivo. J Clin Endocrinol Metab 57 (1983) 160-165
48. Piazza P.V., and La Moal M. Glucocorticoids as a biological substrate of reward: physiological and pathological implications. Brain Res Rev 25 (1997) 359-372
49. Rachamin G., Luttge W.G., Hunter B.E., and Walker D.W. Neither chronic exposure to ethanol nor aging affects type I or type II corticosteroid receptors in rat hippocampus. Exp Neurol 106 (1989) 164-171
50. Rajan V., Edward C.R.W., and Seckl J.R. 11β-Hydroxysteroid dehydrogenase in cultured hippocampal cells reactivates inert 11-dehydrocorticosterone, potentiating neurotoxicity. J Neurosci 16 (1996) 65-70
51. Roy A., Mittal N., Zhang H., and Pandey S.C. Modulation of cellular expression of glucocorticoid receptor and glucocorticoid response element-DNA binding in rat brain during alcohol drinking and withdrawal. J Pharmacol Exp Ther 301 (2002) 774-785
52. Sakai R.R., Monder C., and McEwen B.S. Immunocytochemical localization of 11beta-hydroxysteroid dehydrogenase in hippocampus and other brain regions of the rat. J Neuroendocrinol 4 (1992) 101-106
53. Sandeep T.C., Yau J.L.W., MacLullich A.M.J., Noble J., and Deary I.J. 11 Beta-hydroxysteroid dehydrogenase inhibition improves cognitive function in healthy elderly men and type 2 diabetics. Proc Natl Acad Sci U S A 101 (2004) 6734-6739
54. Sapolsky R.M. Glucocorticoids and hippocampal atrophy in neuropsychiatric disorders. Arch Gen Psychiatry 57 (2000) 925-935
55. Schinkel A.H., Smit J.J.M., Vantellingen O., Beijnen J.H., Wagenaar E., Vandeemter L., Mol Caam, Vandervalk M.A., Robanusmaandag E.C., Teriele H.P.J., Berns A.J.M., and Borst P. Disruption of the mouse mdr1a p-glycoprotein gene leads to a deficiency in the blood-brain-barrier and to increased sensitivity to drugs. Cell 77 (1994) 491-502
56. Seckl J.R., and Walker B.R. Minireview: 11β-Hydroxysteroid dehydrogenase type-1: a tissue specific amplifier of glucocorticoid action. Endocrinology 142 (2001) 1371-1376
57. Sipp T.L., Blank S.E., Lee E.G., and Meadows G.G. Plasma corticosterone response to chronic ethanol consumption and exercise stress. Proc Soc Exp Biol Med 204 (1993) 184-190
58. Tabakoff B., Jaffe R.C., and Ritzmann R.F. Corticosterone concentrations in mice during ethanol drinking and withdrawal. J Pharm Pharmacol 30 (1978) 371-374
59. Tremwel M.F., and Hunter B.E. Effects of chronic ethanol ingestion on long-term potentiation remain even after a prolonged recovery from ethanol exposure. Synapse 17 (1994) 141-148
60. Uhl M., Holsboer F., and Muller M.B. Penetration of endogenous steroid hormones corticosterone, cortisol, aldosterone and progesterone into the brain is enhanced in mice deficient for both mdr1a and mdr1b P-glycoproteins. J Neuroendocrinol 14 (2002) 579-753
61. Watson W.P., and Little H.J. Effects of chronic ethanol consumption on responses to nicotine: interaction with environmental cues. Neuropharmacology 38 (1999) 587-595
62. Watson W.P., and Little H.J. Selectivity of the effects of dihydropyridine calcium channel antagonists against the alcohol withdrawal syndrome. Brain Res 930 (2002) 111-122
63. Weber C.C., Eckert G.P., and Muller W.E. Effect of antidepressants on the brain/plasma distribution of corticosterone. Neuropsychopharmacology 31 (2006) 2443-2448
64. Whittington M.A., and Little H.J. Nitrendipine, given during drinking, decreases the electrophysiological changes in the isolated hippocampal slice, seen during ethanol withdrawal. Br J Pharmacol 103 (1991) 1677-1684
65. Yau L.J.W., Noble J., Kenyon C.J., Hibberd C., and Kotelevtsev Y. Lack of tissue glucocorticoid reactivation in 11-β-hydroxysteroid dehydrogenase type 1 knockout mice ameliorates age-related learning impairments. Proc Natl Acad Sci U S A 98 (2001) 4716-4721
66. Young A.H., Gallagher P., Watson S., Del-Estal D., Owen B.M., and Ferrier I.N. Improvements in neurocognitive function and mood following adjunctive treatment with mifepristone (RU-486) in bipolar disorder. Neuropsychopharmacology 29 (2004) 1538-1545